{
    "code": "02022147",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022147",
    "time": "2020-02-25 12:51:14",
    "許可證字號": "衛署藥輸字第022147號",
    "註銷狀態": "已註銷",
    "註銷日期": "99\/12\/17",
    "註銷理由": "自請註銷",
    "有效日期": "102\/08\/26",
    "發證日期": "87\/04\/29",
    "許可證種類": "製　劑",
    "舊證字號": "02015336",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202214706",
    "中文品名": "&quot;亞培&quot; 達磺素口服懸液用顆粒劑",
    "英文品名": "PEDIAZOLE GRANULES FOR ORAL SUSPERSION",
    "適應症": "兒童因ＨＥＭＯＰＨＩＬＵＳ　ＩＮＦＬＵＥＮＺＡＥ敏感菌種所引起的急性中耳炎",
    "劑型": "151懸液用顆粒劑",
    "包裝": "瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "0932301100  美商亞培股份有限公司台灣分公司",
        "申請商地址": "台北市中山區民生東路三段49號5、6樓及51號5、6樓",
        "主製造廠": ""
    },
    "CCC號列": "30049050000 磺胺藥Antibacterial, sulfa drugs",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812509220",
            "成分名稱": "ERYTHROMYCIN (ETHYLSUCCINATE)",
            "含量描述": "",
            "含量": "200.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "0824009100",
            "成分名稱": "SULFISOXAZOLE (ACETYL)",
            "含量描述": "",
            "含量": "600.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020221470002.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022147&Seq=002&Type=9"
        },
        {
            "title": "020221470002.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022147&Seq=002&Type=8"
        }
    ]
}